EA Mittendorf

Final report of the phase I/II clinical trial of the E75 (nelipepimut-S) vaccine with booster inoculations to prevent disease recurrence in high-risk breast cancer patients

EA Mittendorf, Guy T. Clifton, Jarrod P. Holmes et al. · Annals of Oncology · 2014 · 240 citations · Full text

Vaccination, Vaccinology, Oncology +11

Abstract S2-1: The role of sentinel lymph node surgery in patients presenting with node positive breast cancer (T0-T4, N1-2) who receive neoadjuvant chemotherapy – results from the ACOSOG Z1071 trial

JC Boughey, VJ Suman, EA Mittendorf et al. · Cancer Research · 2012 · 54 citations

Surgical Oncology, Breast Oncology, Cancer Management +19

Surgical Considerations After Neoadjuvant Chemotherapy: Breast Conservation Therapy

Thomas A. Buchholz, EA Mittendorf, K. Hunt · JNCI Monographs · 2015 · 43 citations · Full text

Surgical Oncology, Breast Oncology, Neoadjuvant Chemotherapy +14

Comparison of clinicopathologic features and survival in young American women aged 18–39 years in different ethnic groups with breast cancer

Pei Jun Liu, Xiang Li, EA Mittendorf et al. · British Journal of Cancer · 2013 · 31 citations · Full text

Cyclin E amplification/overexpression is a mechanism of trastuzumab resistance in HER2+ breast cancer patients

EA Mittendorf, Khandan Keyomarsi, K. Hunt · Breast Diseases A Year Book Quarterly · 2011 · 28 citations

Trastuzumab Resistance, Breast Oncology, Oncology +9